Correlation Between Ironwood Pharmaceuticals and Merck

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Ironwood Pharmaceuticals and Merck at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Ironwood Pharmaceuticals and Merck into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Ironwood Pharmaceuticals and Merck Company, you can compare the effects of market volatilities on Ironwood Pharmaceuticals and Merck and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Ironwood Pharmaceuticals with a short position of Merck. Check out your portfolio center. Please also check ongoing floating volatility patterns of Ironwood Pharmaceuticals and Merck.

Diversification Opportunities for Ironwood Pharmaceuticals and Merck

  Correlation Coefficient

Good diversification

The 3 months correlation between Ironwood and Merck is -0.16. Overlapping area represents the amount of risk that can be diversified away by holding Ironwood Pharmaceuticals and Merck Company in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Merck Company and Ironwood Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Ironwood Pharmaceuticals are associated (or correlated) with Merck. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Merck Company has no effect on the direction of Ironwood Pharmaceuticals i.e., Ironwood Pharmaceuticals and Merck go up and down completely randomly.

Pair Corralation between Ironwood Pharmaceuticals and Merck

Given the investment horizon of 90 days Ironwood Pharmaceuticals is expected to under-perform the Merck. In addition to that, Ironwood Pharmaceuticals is 4.49 times more volatile than Merck Company. It trades about -0.26 of its total potential returns per unit of risk. Merck Company is currently generating about 0.14 per unit of volatility. If you would invest  12,700  in Merck Company on February 24, 2024 and sell it today you would earn a total of  409.00  from holding Merck Company or generate 3.22% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
ValuesDaily Returns

Ironwood Pharmaceuticals  vs.  Merck Company

Ironwood Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

Very Weak
Over the last 90 days Ironwood Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of inconsistent performance in the last few months, the Stock's basic indicators remain rather sound which may send shares a bit higher in June 2024. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.
Merck Company 

Risk-Adjusted Performance

3 of 100

Compared to the overall equity markets, risk-adjusted returns on investments in Merck Company are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Despite quite persistent basic indicators, Merck is not utilizing all of its potentials. The recent stock price mess, may contribute to short-term losses for the institutional investors.

Ironwood Pharmaceuticals and Merck Volatility Contrast

   Predicted Return Density   

Pair Trading with Ironwood Pharmaceuticals and Merck

The main advantage of trading using opposite Ironwood Pharmaceuticals and Merck positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Ironwood Pharmaceuticals position performs unexpectedly, Merck can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Merck will offset losses from the drop in Merck's long position.
The idea behind Ironwood Pharmaceuticals and Merck Company pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.

Other Complementary Tools

Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios